Human CTC1-STN1-TEN1 (CST) is an RPA-like single-stranded DNA binding protein that interacts with DNA polymerase a-primase (pol a) and functions in telomere replication. Previous studies suggest that CST also promotes replication restart following fork stalling. However, the precise role of CST in genome-wide replication remains unclear. In this study, we sought to understand whether CST alters origin licensing and activation. Replication origins are licensed by loading of the minichromosome maintenance 2-7 (MCM) complex in G1 followed by replisome assembly and origin firing in S-phase. We find that CST directly interacts with the MCM complex and disrupts binding of CDT1 to MCM, leading to decreased origin licensing. We also show that CST enhances replisome assembly by promoting AND-1/pol a chromatin association. Moreover, these interactions are not dependent on exogenous replication stress, suggesting that CST acts as a specialized replication factor during normal replication. Overall, our findings implicate CST as a novel regulator of origin licensing and replisome assembly/fork progression through interactions with MCM, AND-1 and pol a.
Introduction
DNA replication must occur with high fidelity and efficiency to preserve genome stability. Each time human cells divide 50,000-100,000 DNA replication origins are activated for genome duplication (Higa, Fujita et al., 2017 , Zhai, Li et al., 2017b . During telophase and G1, replication origins are licensed by binding of the origin recognition complex (ORC) and CDC6 to the DNA, followed by recruitment of CDT1 and minichromosome maintenance 2-7 (MCM) to form the pre-replication complex (pre-RC). Loading of the first MCM hexamer by ORC and CDC6 leads to the ORC-CDC6-CDT1-MCM (OCCM) complex. A second MCM hexamer is then recruited and loaded onto the DNA for origin licensing. Recruitment and loading of MCMs are dependent on CDT1. CDT1 facilitates interaction between MCM and ORC-CDC6 and also stabilizes opening of the MCM hexamer for loading onto the DNA (Frigola, He et al., 2017 , Masai, Matsumoto et al., 2010 , Pozo & Cook, 2016 . Once the first MCM hexamer is loaded, CDT1 and CDC6 are released. A second MCM-CDT1 complex along with CDC6 then bind ORC, leading to loading of a second MCM hexamer (Ticau, Friedman et al., 2017 , Ticau, Friedman et al., 2015 . Loading of the two MCM hexamers constitutes a licensed replication origin. Origin licensing is restricted to telophase and G1 of the cell cycle to prevent re-replication in S-phase. Unlike budding yeast, origin licensing in mammals is not defined by DNA sequence but by chromatin context and accessibility (Cayrou, Ballester et al., 2015) .
Upon entering S-phase, replication factors are recruited to origins to form the pre-initiation complex (pre-IC). MCM is bound by CDC45 and GINS to form the CDC45-MCM-GINS (CMG) complex, which serves as the replicative helicase (Deegan & Diffley, 2016) . Three DNA polymerases (pol) are recruited during replisome assembly and used for DNA synthesis upon origin firing. Pol e binds directly to CMG, while pol d and pol a-primase (pol a) are linked to the replisome by PCNA and Ctf4/AND-1, respectively. Once assembled, the replisome is then activated, or fired, following phosphorylation of MCM by Dbf4-dependent kinase (DDK) and cyclindependent kinase (CDK). Origin licensing and activation was recently reconstituted with purified replication factors from budding yeast (Yeeles, Deegan et al., 2015) . However, many questions remain, particularly in regards to where replication origins are licensed in higher eukaryotes and how they are selected for activation. Here, we identify human CTC1-STN1-TEN1 (CST) as a novel regulator of origin licensing and replisome assembly. CST is an RPA-like ssDNA binding protein that has primarily been characterized as a telomere replication factor with less well understood roles in genome-wide replication (Stewart, Wang et al., 2018) .
Our previous work indicated that CST promotes origin firing in response to genome-wide replication stress . In addition, work by Chastain et al. showed that CST recruits RAD51 to rescue stalled replication and prevent chromosome fragility at GC-rich DNA (Chastain, Zhou et al., 2016) . However, the mechanism by which CST facilitates replication restart remains unclear. CTC1 and STN1 were originally discovered as pol a accessory factors (Casteel, Zhuang et al., 2009 , Goulian, Heard et al., 1990 . CST stimulates pol a primase activity and the primase-to-polymerase switch (Ganduri & Lue, 2017 , Nakaoka, Nishiyama et al., 2012 .
Nevertheless, CST does not localize to active replication forks, suggesting it may function prior to replication initiation and/or at stalled replication forks (Miyake, Nakamura et al., 2009 , Sirbu, McDonald et al., 2013 . Moreover, depletion of CST subunits does not alter bulk DNA replication under normal conditions but does result in increased anaphase bridges and chromosome fragility, suggesting that CST is likely utilized at specific regions of the genome (Chastain et al., 2016 , Wang & Chai, 2018 .
In agreement with this idea, in vitro biochemical analysis revealed that CST binds and resolves G-quadruplexes (G4s) (Bhattacharjee, Wang et al., 2017) . ChIP-seq analysis also demonstrated that STN1 localizes to non-telomeric GC-rich regions, which are known to form G4s (Chastain et al., 2016) . G4s are stable, four-stranded structures that can block replication, regulate transcription and are associated with several diseases (Maizels, 2015 , Rhodes & Lipps, 2015 . G4s are also enriched at DNA replication origins and may promote origin licensing (Valton & Prioleau, 2016) .
During telomere replication, CST participates in many of the steps required for telomere maintenance. These steps include replication of the telomere duplex, removal of telomerase, prevention of ATR activation and engagement of pol a for C-strand fill-in synthesis (Chen, Redon et al., 2012 , Feng, Hsu et al., 2018 , Feng, Hsu et al., 2017 , Gu & Chang, 2013 , Gu, Min et al., 2012 , Kasbek, Wang et al., 2013 , Miyake et al., 2009 , Surovtseva, Churikov et al., 2009 . CST was also recently shown to interact with the shieldin complex to counteract double-strand break (DSB) end resection by facilitating fill-in by pol a, similar to its role in telomeric C-strand fill-in (Barazas, Annunziato et al., 2018 , Mirman, Lottersberger et al., 2018 . This multi-functionality of CST in telomere maintenance, DSB repair and replication rescue is not unexpected given its similarity to RPA.
RPA directs various transactions during DNA replication and repair through the use of multiple oligonucleotide-oligosaccharide binding (OB)-folds, which allow RPA to bind ssDNA of different lengths and configurations (e.g. ss-dsDNA junctions) (Chen & Wold, 2014 , Fanning, Klimovich et al., 2006 . Like RPA, CST is composed of multiple OB-folds, which allow it to bind different form of ssDNA (Bhattacharjee et al., 2017 , Chen et al., 2012 , Miyake et al., 2009 ). However, while CST and RPA have similar binding affinities, CST, unlike RPA, is in low abundance and may require recruitment to specific sites. For example, recruitment of CST to DSBs is dependent on the shieldin complex, whereas TPP1 appears to localize CST to telomeres (Chen et al., 2012 , Mirman et al., 2018 . Use of CST may be advantageous because, unlike RPA, its binding does not elicit ATR activation (Feng et al., 2017) .
Mutations in CTC1 and STN1 cause two pleiotropic autosomal recessive disorders, Coats plus and dyskeratosis congenita (Anderson, Kasher et al., 2012 , Keller, Gagne et al., 2012 , Polvi, Linnankivi et al., 2012 , Simon, Lev et al., 2016 . Dyskeratosis congenita is caused by accelerated telomere shortening, which leads to cell proliferation defects and ultimately bone marrow failure (Armanios & Blackburn, 2012 , Stanley & Armanios, 2015 . Coats plus shares features of dyskeratosis congenita but has additional features, including intercranial calcifications, retinopathy, intrauterine growth retardation and gastrointestinal bleeding (Briggs, Abdel-Salam et al., 2008) . Interestingly, some Coats plus patients do not exhibit accelerated telomere shortening, suggesting that both telomere and non-telomere defects contribute to the disease (Kotsantis, Petermann et al., 2018 , Polvi et al., 2012 , Romaniello, Arrigoni et al., 2013 . Thus, determining the different roles of CST in preserving genome stability is necessary to characterize the molecular etiology of these diseases.
Here, we present evidence that CST interacts with the MCM complex and suppresses origin licensing by disrupting the interaction between MCM and CDT1. Furthermore, we find that CST is important for recruitment/stabilization of AND-1 and pol a on the chromatin. Interestingly, regulation of both origin licensing and AND-1/pol a chromatin association occur in the absence of HU-induced replication fork stalling, suggesting that these functions are independent of CST's role in origin activation following exogenous replication stress. Together, our results support a direct role for CST in both origin licensing and replication activation.
Results

STN1 depletion leads to increased levels of chromatin-bound MCM
Since the precise role(s) of CST in general replication are poorly understood, we tested whether CST affects the levels of chromatin-bound MCM in the absence of replication stress, as this would suggest changes in origin licensing and activation. To determine whether depletion of STN1 alters MCM levels, we used previously characterized HeLa1.2.11 cells with stable shRNA STN1 knockdown (shSTN1) to measure the levels of chromatin-bound MCM (Figure 1) . Cells expressing a non-targeting shRNA (shNT) or shSTN1 cells expressing an shRNA resistant Flag-STN1 (shSTN1-Res) were used as controls ( Figure 1A ). EdU was added to the cultures 30 min prior to sample processing, which enabled later identification of S-phase cells (see Figure 2A ). Cells were then harvested, pre-extracted to remove soluble MCM, fixed and examined by indirect immunofluorescence (IF) to detect chromatin-bound MCM7, MCM3 or MCM6 ( Figure 1B -C). MCM fluorescence intensity was measured in each nucleus and the MCM signal intensity compared between cell lines ( Figure 1C ). The analysis revealed that the levels of chromatin-bound MCM7, MCM3 and MCM6 were significantly increased in shSTN1 cells compared to controls. These results were confirmed in HCT116 shSTN1 cells for chromatin-bound MCM6 ( Figure EV1A-B) . The increase is specific to chromatin-bound MCM, as total cellular MCM3, MCM6 or MCM7 levels were similar in shSTN1 and controls cells ( Figure EV1C ). These findings indicate that depletion of STN1 significantly increases chromatin-bound MCM.
CST overexpression leads to decreased chromatin-bound MCM
We next tested whether CST overexpression (CST-OE) also affected MCM chromatin association. For this experiment, we used a previously described HeLa cell line overexpressing all three CST subunits ( Figure 1D ) (Wang, Stewart et al., 2014) . IF was performed, as described above, for either MCM7 ( Figure 1E -F) or MCM6 ( Figure EV1D ). CST-OE had the reverse effect to STN1 depletion as it led to a substantial decrease in chromatin-bound MCM. Together, the results in Figure 1 indicate that the level of chromatin-bound MCM is inversely proportional to CST expression. It is notable that the changes in MCM occur in the absence of exogenous replication stress, which indicates that CST is needed to regulate MCM under normal conditions rather than in response to genome-wide replication fork stalling or DNA damage.
STN1 depletion leads to increased MCM in G1 and S-phase
We next wanted to determine whether the changes in chromatin-bound MCM were due to alterations in loading of MCM in G1 or unloading in S/G2. MCM loading onto the chromatin is tightly regulated throughout the cell cycle with origin licensing restricted to telophase and G1.
MCM is then unloaded from the chromatin following DNA synthesis in a ubiquitin-dependent manner (Dewar, Budzowska et al., 2015 , Dewar, Low et al., 2017 , Moreno, Bailey et al., 2014 , Sonneville, Moreno et al., 2017 . In initial experiments, we determined the effect of STN1 knockdown on the levels of chromatin-bound MCM in EdU positive versus negative cells ( Figure   1B and 2A). This allowed us to distinguish whether the increase was restricted to S-phase. We found that MCM6 levels significantly increased in both EdU positive and EdU negative shSTN1 cells, indicating that the increase in MCM occurs both outside and within S-phase ( Figure 2A ).
Since the above experiments did not distinguish between cells in G1 versus G2, we next performed flow cytometry to separate MCM positive cells in G1 and G2/M populations. This allowed us to address whether the changes in chromatin-bound MCM reflected increased MCM loading (i.e. origin licensing) in G1 versus MCM dissociation in S/G2. HeLa control and shSTN1 cells were labeled with EdU for 30 min, pre-extracted to remove soluble MCM, stained for MCM6 and EdU and then separated by flow cytometry for cell cycle analysis ( Figure EV2A ). Cells were then gated to separate G1, S and G2/M populations ( Figure EV2B -D and see Materials and Methods). The analysis revealed no observable change in the number or intensity of EdU positive cells with STN1 depletion compared to controls, suggesting DNA synthesis is not significantly affected with STN1 depletion, as previously reported ( Figure 2B ) (Wang et al., 2014 . Likewise, when we compared chromatin-bound MCM across the cell cycle, we found the expected increase in MCM positive cells in G1 (origin licensing) followed by a linear decrease throughout S-phase (origin firing/DNA synthesis) with very few MCM6 positive cells in G2/M ( Figure 2B ) (Matson, Dumitru et al., 2017) . However, the G1 population of shSTN1 cells exhibited an increase in MCM6 intensity compared to the control cells in mean intensity of MCM6 positive cells, suggesting increased origin licensing after STN1 depletion ( Figure 2C -E). There was also an increase in MCM intensity in S-phase and G2/M ( Figure 2E ). However, very few MCM positive cells were within the G2/M population, which was unchanged with STN1 depletion (Figure 2E , MCM positive cells in G2/M: shNT=1.5%, shSTN1=1.5%, shSTN1-Res=1.4%). These data argue against a defect in MCM removal following replication termination because this should lead to an increase in the fraction of MCM positive cells in G2/M. Instead, our results demonstrate that CST suppresses origin licensing in G1. Similar results were observed in HCT116 shSTN1 cells ( Figure   EV2F -H). Overall, these results provide evidence that CST regulates origin licensing (i.e. MCM loading in G1). Furthermore, we find that chromatin-bound MCM increases in S-phase, which is likely caused, at least in part, by excess origin licensing in G1.
CST interacts with the MCM complex
Since CST affects origin licensing, we next tested whether CST interacts with MCM ( Figure 3 ).
First, co-immunoprecipitation (co-IP) experiments were performed using whole cell lysates from cells expressing CST subunits. HA-tagged CTC1, Flag-tagged STN1, or untagged TEN1 were transiently expressed in combination or individually. The lysates were nuclease-treated prior to IP to ensure that the interaction was not DNA-dependent. Association of MCM subunits or CDC45 with CST was then assessed by Western blot ( Figure 3A ). MCM4 and MCM7 coimmunoprecipitated with CTC1 or STN1 ( Figure 3A ). CDC45, a component of the CMG complex, was also detected. Interaction with MCM was confirmed by reciprocal co-IP, where endogenous MCM7 was pulled down and STN1 detected ( Figure 3B ). Co-IP was also performed following HU treatment to see if interactions between CST and MCM or CDC45 was increased upon HUinduced fork stalling. However, neither interaction was significantly altered in response to HU treatment ( Figure EV3A-B ).
Next, yeast-two-hybrid analysis was performed to more closely examine the interaction between CST and MCM, and to identify which subunit(s) interact. Human CTC1, STN1 or TEN1 coding regions were fused with the GAL4 DNA-binding domain (BD), while human MCM subunits or CDC45 were linked to the GAL4 DNA-activation domain (AD). Combinations of the constructs were then transformed into yeast, selected and spotted onto double synthetic dropout (DDO) medium, lacking histidine and tryptophan, or quadruple dropout (QDO) medium, lacking tryptophan, leucine, adenine and histidine. The DDO media was used to select for plasmid transformations and QDO media for cells producing adenine and histidine, which indicates protein interaction. Western blot of whole cell lysate was also performed to confirm the expression of MCM subunits, CDC45 and CST subunits ( Figure 3C ).
Among the different MCM subunits, we identified strong interactions between STN1 with MCM4 and MCM7 ( Figure 3C ). A weak interaction was also observed between CTC1 and MCM4 on the less stringent triple synthetic dropout (TDO) medium ( Figure EV3C ). TEN1 did not interact with any MCM subunit. Together, our results identify a direct interaction between STN1 and the MCM4-MCM7 interface. Interestingly, this region sits opposite the MCM2-MCM5 gate, suggesting that CST would not block opening of the gate or binding of CDC45 and GINS , Zhai et al., 2017b . We also tested CDC45 and CST subunits for interaction in the yeast-twohybrid assay and did not observe any growth on the TDO or QDO media, which suggest that their association, detected by co-IP, may be bridged by MCM ( Figure 3C ). Alternatively, multiple CST subunits could be required for interaction, as is the case for CST interaction with pol a (Bhattacharjee et al., 2017 , Feng et al., 2018 . Overall our results demonstrate that CST interacts with MCM, with strong interaction between STN1 and MCM4-MCM7. Based on the yeast-twohybrid data, we propose that this interaction is direct. However, it is possible that an evolutionaryconserved protein could bridge the interaction.
CST disrupts the interaction between MCM and CDT1
We next sought to determine whether CST binding to MCM was the underlying cause of decreased origin licensing by CST. As mentioned previously, CDT1 plays an essential role in the recruitment and loading of MCM. Since CST interacts with MCM, we hypothesized that binding of CST could obstruct or destabilize CDT1 binding to MCM. Recent biochemical analysis of budding yeast MCM and Cdt1 showed that Cdt1 interacts with MCM2 and MCM6, and weakly with MCM4 (Frigola et al., 2017) . Human CDT1 has also been shown to interact with MCM6 (Liu, Wu et al., 2012) . To more closely examine the interaction between MCM and CDT1 in humans, we performed yeast-two-hybrid analysis ( Figure 4A ). In agreement with previous studies, we observed a strong interaction between CDT1 and MCM6. Additionally, we find a weaker interaction between CDT1 and MCM4, similar to budding yeast Cdt1. These findings suggest that CST and CDT1 have overlapping binding surfaces (i.e. CST binds MCM4-MCM7 while CDT1 binds MCM6-MCM4).
To test whether CST disrupts CDT1 binding to MCM, CDT1-HA, Flag-MCM subunits and/or CST were expressed in HEK 293T cells. Flag-tagged MCM2, MCM4 or MCM6 was then immunoprecipitated. The levels of CDT1-HA associated with MCM were then measured with or without expression of the entire CST complex (+CST) or just CTC1 and STN1 (+CS) ( Figure 4B and EV4). As expected, CDT1 associated with MCM4 and MCM6 in the control (no CST or CS).
Association was also observed with MCM2. However, when CST was co-expressed, we observed a decrease in CDT1 levels, suggesting that CST disrupts MCM-CDT1 interaction.
One caveat was that expression of MCM subunits and CDT1 varied to some extent across samples. To account for these differences, we normalize to the amount of MCM pulled down in +CST or +CS samples to MCM IPs without CST expression (see Materials and Methods for more details). Furthermore, we normalized the levels of CDT1 in the MCM IP to the CDT1 input levels.
Relative CDT1 levels were then quantified in the MCM IP +CST or +CS compared to MCM IP samples without CST expression ( Figure 4B and EV4, numbers below blot). Here, we observed a significant decrease in CDT1 binding to MCM in the presence of CST. Interestingly, when only CTC1 and STN1 were expressed, the decrease in CDT1 binding to MCM, while still significant, was not as severe as expression of the entire CST complex. This indicates that binding of TEN1, which likely alters the confirmation of CTC1 and STN1, also contributes to the inhibition of CDT1 binding to MCM. These striking findings indicate that CST disrupts the interaction between MCM and CDT1. We propose that this occurs through CST blocking the CDT1 interaction site on MCM, which prevents/obstructs stable binding of CDT1 ( Figure 4C ). Disruption of the MCM-CDT1 interaction would directly affect origin licensing (i.e. MCM loading) by preventing MCM recruitment, thus explaining why CST decreases origin licensing.
STN1 chromatin association increases in S-phase
While examining the levels of chromatin-bound MCM, we also determined whether CST chromatin association changed throughout the cell cycle. HeLa cells stably expressing Flag-STN1 were synchronized by double-thymidine block and collected 0, 1.5, 3, 6, 9, 12 and 24h after release. Flow cytometry was used to verify cell synchronization and EdU incorporation to identify cells in S-phase ( Figure 5A ). Western blot analysis for STN1 was then performed on chromatin fractions ( Figure 5B ). At the 1.5-6 h time points, cells were predominately in S-phase and transitioned to G2/M by 9 h. While a small fraction of STN1 remains chromatin-bound throughout the cell cycle, STN1 levels significantly increased on the chromatin at the 1.5-6 hr timepoints ( Figure 5B ), suggesting that CST is recruited to the chromatin during S-phase. Significantly, the timing of this increase differs from the timing of increased CST telomere association, which occurs in late S/G2 (Chen et al., 2012) .
CST interacts with AND-1 and promotes AND-1 and pol a chromatin binding
Previous studies have shown that CST interacts with pol a and depletion of CST subunits leads to anaphase bridges and chromosome fragility in the absence of exogenous replication stress (Chastain et al., 2016 , Chen, Majerska et al., 2013 , Goulian et al., 1990 , Wang & Chai, 2018 . These observations suggest CST plays additional roles in DNA replication beyond origin licensing. Given that CST is recruited to the chromatin in Sphase and interacts with pol a, we wondered whether CST promotes replisome assembly and origin firing, particularly whether CST affects the association of AND-1 and pol a with the replisome.
Prior to origin firing, pol a is coupled to the replisome by AND-1 (Simon, Zhou et al., 2014) .
Since CST also physically and functionally interacts pol a, we hypothesized that CST may assist or replace AND-1 to link pol a to the replisome under certain situations, such as at G4s or other GC-rich DNA, which are enriched at origins. AND-1, also known as Ctf4 and WDHD1, is a homotrimeric complex composed of conserved WD40 repeats and a SepB domain (Guan, Li et al., 2017) . Human AND-1 also contains a HMG domain, which facilitates its interaction with pol a, and was recently shown to bind to ssDNA in vitro, which may help to it position pol a for primer synthesis (Kilkenny, Simon et al., 2017) .
We first tested whether depletion of STN1 altered chromatin-bound AND-1 in HeLa cells.
The cells were pre-extracted and chromatin-associated AND1 was measured by IF ( Figure 6A -B). STN1 knockdown caused a significant decrease in AND-1 levels, suggesting that CST promotes AND-1 chromatin binding. To ensure that CST had not decreased total cellular AND-1, we checked AND-1 levels in whole cell lysates, where AND-1 was slightly increased in the shSTN1 and shSTN1-Res compared to shNT cells ( Figure EV5 ). While the reason for these changes are not clear, they indicate that decreased AND-1 chromatin association is not due to decreased cellular AND-1 levels. We also examined AND-1 and pol α in HCT116 shSTN1 cells and found a decrease in both AND-1 and pol a chromatin association ( Figure 6C ). These findings fit with a role for CST in replisome assembly, as AND-1 association is needed for pre-IC formation.
However, it is interesting to note that only a fraction of AND-1 is lost from the chromatin, suggesting that CST is only required at subset of replication origins to recruit AND-1.
To address the possibility that CST indirectly affects AND-1 levels, we next determined whether AND-1 and CST physically associate. Co-IP was performed in cells expressing Flag-STN1, HA-CTC1 or the entire CST complex. We found that STN1 alone or in complex with CST interact with AND-1 ( Figure 6D ). These results provide evidence that CST directly aids in the loading of AND-1/pol a on the chromatin and hence with the replisome.
Given our previous finding that CST promotes dormant origin firing in response to HU treatment, we next asked whether the dependence of AND-1 on CST for its chromatin association could explain how CST promotes dormant origin firing in response to genome-wide replication fork stalling , Wang et al., 2014 . Although HU inhibits global origin firing, it promotes the firing of dormant replication origins nearby stalled forks (Ge & Blow, 2010) . We hypothesized that CST might enable firing of these dormant origins by recruiting AND-1/pol a. A prediction of this hypothesis is that STN1 knockdown would decrease AND-1 association with dormant origins nearby forks that stalled following HU treatment. If correct, then this would cause an additional decrease in chromatin-bound AND-1 on top of the decrease already observed after STN1 knockdown in the absence of HU treatment. Thus, the effect of STN1 knockdown on AND-1 chromatin association should be much larger in HU-treated cells.
To test whether fork stalling affected AND-1 levels on the chromatin, cells were treated with HU for 2 h and IF for AND-1 performed ( Figure 6B ). With HU treatment, we observed decreased AND-1 chromatin association across all cell lines, suggesting that HU-induced replication fork stalling causes an overall decrease in AND-1 chromatin association. This overall decrease in AND-1 is likely due to the repression of global origin firing. When STN1 depleted cells were treated with HU, we observed an additional decrease in AND-1 chromatin association relative to control cells. However, the magnitude of the decrease was the same in the HU-treated and untreated cells (~15%). Since the effect of STN1 knockdown was not magnified in HU-treated cells, this finding indicates that CST is unnecessary for AND-1 to associate with the dormant origins that are fired in response to genome-wide replication fork stalling. We therefore infer that CST associates with AND-1 and pol a to stabilize replisome formation at a subset of origins that are active during an unperturbed cell cycle.
Discussion
In this study, we show that CST regulates two different aspects of DNA replication. First, CST interacts with the MCM complex and disrupts its interaction with CDT1, leading to the suppression of origin licensing. Second, CST associates with AND-1 to promote AND-1 and pol a chromatin association, presumably with the replisome. It is striking that CST functions in two quite separate aspects of DNA replication but this is perhaps not surprising given the RPA-like nature of CST and that RPA also functions in multiple aspects of DNA replication and repair (Fanning et al., 2006) . Moreover, CST has already been shown to play distinct roles in several aspects of telomere replication (Stewart et al., 2018) . It is interesting that the newly discovered roles of CST in origin licensing and replisome assembly are independent of global replication fork stalling, as this suggests that CST's roles in dormant origin firing and RAD51 recruitment following genomewide fork stalling are distinct activities (Chastain et al., 2016 , Wang & Chai, 2018 . At present, the mechanism by which CST facilitates replication restart following genomewide fork stalling and whether it is directly or indirectly mediated is unclear. However, here we show direct involvement of CST in origin licensing and replisome assembly.
Origin licensing requires CDT1 interaction with MCM to enable MCM binding to ORC/CDC6 and sequential loading of two MCM hexamers on the chromatin (Ticau et al., 2017 , Ticau et al., 2015 . Our results demonstrate that CST disrupts the interaction between MCM and CDT1 (Figure 4) , which explains how CST suppresses origin licensing ( Figure 7A ). Prior structural analysis of yeast MCM and OCCM complexes, combined with our current data, provide insight into the molecular details whereby CST blocks the MCM-CDT1 interaction and MCM loading (Abid Ali, Douglas et al., 2017 , Li, Zhai et al., 2015 , Yuan, Bai et al., 2016 , Yuan, Riera et al., 2017 , Zhai, Cheng et al., 2017a , Zhai et al., 2017b . Our yeast-two-hybrid results indicate that STN1 strongly interacts with the MCM4-MCM7 interface (Figure 3) . Within the MCM hexamer, MCM4-MCM7 are located opposite of the MCM2-MCM5 gate used for loading MCM. Recent work suggests that, in yeast, CDT1 interacts with the MCM2-MCM6-MCM4 interface and stabilizes an open ring conformation for MCM loading (Frigola et al., 2017) . Additionally, NMR studies showed that the C-terminal domain of MCM6 interacts with CDT1, suggesting a similar binding interface in human cells (Liu et al., 2012 , Wei, Liu et al., 2010 . Finally, we find that human CDT1 also interacts with MCM4 ( Figure 4A ).
Binding of CST to MCM4, which is adjacent to MCM6, could destabilize/block the interaction between CDT1 and MCM (see Figure 3C ), leading to a closed ring conformation and the inability for MCM to interact with ORC/CDC6 ( Figure 7A ). Alternatively, CST binding could cause a conformational shift that prevents CDT1 binding to MCM. Disruption of the MCM-CDT1 interaction may be used to prevent the loading of malformed or incomplete MCM hexamers at origins, or overloading of MCM at specific regions of the genome, which could affect replication timing (Das, Borrman et al., 2015) . In budding yeast, CDC6 is known to prevent unproductive MCM loading following OCCM formation (Frigola, Remus et al., 2013) . CST could provide an additional quality control mechanism to prevent unproductive MCM loading prior OCCM formation. However, further studies are needed to determine the precise role of CST in preventing origin licensing.
With regard to the timing of CST association with MCM, studies to detect replisomeassociated proteins have failed to detect CST at replisomes actively synthesizing DNA (Miyake et al., 2009 , Sirbu et al., 2013 . However, our data suggest that CST interacts with CMG prior to origin firing. These data suggest that CST interacts with MCM during pre-RC/replisome formation and may not be required during normal DNA synthesis. Instead, we propose that CST is recruited at regions of difficult-to-replicate G-rich DNA to promote replication restart and replication initiation by recruiting AND-1/pol a (Figure 7) . Altered origin licensing can have a profound impact on genome stability, particularly when combined with defects in other pre-RC or pre-IC factors or oncogene-induced replication stress (Kotsantis et al., 2018) . For example, mutations in pre-RC factors, which decrease origin licensing, are known to cause Meier-Gorlin syndrome, a primordial dwarfism disorder (Bicknell, Bongers et al., 2011 , Bicknell, Walker et al., 2011 . Changes in STN1 mRNA expression were also reported in a number of cancers (Chastain et al., 2016) . Thus, future research is required to determine how changes in CST expression or mutations affect origin licensing under different conditions. It will also be essential to understand the extent to which defects in origin licensing are counterbalanced with other CST-related functions, such as dormant origin activation following replication stress.
We also find that CST interacts with AND-1 ( Figure 5 ). AND-1 is important for recruitment of pol a, and may also act as a hub for the localization of other proteins to the replisome (Hao, de Renty et al., 2015 , Im, Ki et al., 2009 , Yoshizawa-Sugata & Masai, 2009 , Zhu, Ukomadu et al., 2007 . Additionally, AND-1 has ssDNA-binding activity, which may help position pol a for replication (Kilkenny et al., 2017) . A recent report demonstrated that auxin-induced degradation of AND-1, in DT40 cells, caused large stretches of ssDNA, DNA damage and G2 arrest but, surprisingly, AND-1 degradation did not prevent the initiation of DNA synthesis (Abe, Kawasumi et al., 2018) . The ability of AND-1 deficient cells to still initiate replication may reflect a role for other factors, such as CST and MCM10, in linking pol a to the replisome. However, without AND-1, uncoupling of pol a from the replisome is likely to be common, leading to ssDNA gaps and incomplete replication (Im et al., 2009 , Zhu et al., 2007 .
Since G4s are enriched at replication origins (Valton & Prioleau, 2016) , we propose that the interaction between CST and AND-1 may be necessary at specific regions of the genome, such as G4s or GC-rich DNA, which could block AND-1 binding. Here, we envision that CST interacts with MCM and removes DNA secondary structures that may form upon initial unwinding but prior to DNA synthesis ( Figure 7B ) (Bhattacharjee et al., 2017) . CST could then recruit/stabilize AND-1 and pol a to the replisome followed by CST dissociation. This role for CST would be akin to the RPA "hand-off" mechanism, where RPA guides the recruitment of specific proteins to the DNA, which then trade places with RPA through sequentially dissociation of its OB-folds (Chen & Wold, 2014 , Fanning et al., 2006 . AND-1 would then position pol a to initiate DNA synthesis. A similar situation could occur at replication forks stalled by G4s or other secondary structures. Here, CST would resolve the block and then recruit AND-1/pol a to reinitiate DNA synthesis. Since CST interacts with MCM and pol a, it is also possible that CST may substitute for AND-1 under certain conditions, as discussed above. It is formally possible that CST could also assist AND-1 with fork restart, fork protection or DNA damage signaling (Abe et al., 2018 , Chen, Liu et al., 2017 , Hao et al., 2015 . However, these scenarios seem unlikely because HU-induced fork stalling did not influence the interaction between CST and AND-1 or further decrease AND-1 levels with STN1 knockdown ( Figure 6 ).
Defects in the recruitment of AND-1/pol a to the replisome could explain the increased anaphase bridges and chromosome fragility seen after depletion or deletion of CST subunits even though bulk, genome-wide DNA replication (as assayed by EdU uptake) remains unaffected (Chastain et al., 2016 , Wang & Chai, 2018 . The ~15% decrease in chromatin-bound AND-1 in STN1 depleted cells suggests that CST is required for AND-1 association at only a subset of origins. Replication blocks at these origins (e.g. G-rich regions) could prevent origin firing, leading to anaphase bridges or chromosome fragility without affecting bulk DNA replication. Such a requirement for CST would fit with CST being a specialized, as opposed to, a general replication factor. In this case, binding of CST, rather than RPA, would be advantageous because it could resolve the replication block without activating ATR and a subsequent DNA damage response.
Overall, our findings provide evidence that CST functions in two distinct aspects of genome-wide DNA replication, namely origin licensing and replisome assembly. CST was previously shown to interact with pol a and stimulate its activity. Here, we demonstrate that CST interacts with additional replisome components, MCM and AND-1. Future work to untangle how CST expression affects origin licensing, replisome assembly and replication dynamics will help to clarify the non-telomeric roles of CST. Furthermore, determining whether CTC1 or STN1 mutations, arising in Coats plus patients, affect origin licensing and firing through interactions with AND-1 and MCM may help to decipher the molecular pathogenesis of this disease.
Materials and methods
Cell Culture
HeLa 1.2.11 cells were maintained in RPMI 1640 media, HCT116 in McCoy's 5A media and HEK 293T and HeLa TetOn in DMEM at 37°C with 5% CO2. All cell lines were supplemented with 10% Fetal Bovine Serum and 1% Penicillin/Streptomycin. Media for HeLa1.2.11 and HCT116 shRNA knockdown cells also contained puromycin (1 μg/mL, Gibco) to maintain selection . Doxycycline (1 μg/mL, Sigma) was added to HeLa TetOn wild type and CST overexpressing (CST-OE) cells, as previously described (Wang et al., 2014) . Cell lines were regularly checked for mycoplasma contamination.
Whole Cell Extraction
Cell pellets were suspended in lysis buffer (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM MgCl2, 0.1% Igepal, Protease Inhibitors [1 µg/mL Pepstatin A, 5 µg/mL Leupeptin, 1 µg/mL E64, 2 µg/mL Aprotinin, 5 µg/mL Antipain], Phosphatase Inhibitors [4 mM b-glycerophosphate, 4 mM sodium vanadate, 20 mM sodium fluoride]) and incubated on ice for 15 minutes. The samples were then sonicated 3 times (10 sec on/5 sec off) at 40% amplitude, and rested on ice for 5-10 minutes.
Extracts were treated with Benzonase (0.0625 U/μL, EMD Millipore) for one hour on ice followed by centrifugation at 19,000 x g at 4°C for 5 minutes. The supernatant was collected and analyzed by Western blot. Protein concentrations were determined with the BCA assay (Thermo Scientific).
Chromatin Fractionation
Cell pellets were suspended in lysis buffer (10 mM Tris pH 7.5, 100 mM NaCl, 1 mM MgCl2, 0.34 M sucrose, 0.1% Triton-X, 1mM DTT, Protease Inhibitors, Phosphatase Inhibitors) and then rotated at 4°C for 30 minutes, before centrifugation at 19,000 x g for 20 minutes at 4°C. The supernatant was saved as the cytosolic fraction. The pellet was re-suspended in soluble nuclear lysis buffer (10 mM Tris pH 7.5, 100 mM NaCl, 1 mM MgCl2, 0.34 M sucrose, 1mM DTT, Protease Inhibitors, Phosphatase Inhibitors) using one half of the volume of the lysis buffer used above.
The samples were incubated at 37°C for 10 minutes and centrifuged at 19,000 x g. The supernatant was removed and the pellet re-suspended in RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, 1 mM DTT, Protease Inhibitors, Phosphatase Inhibitors) followed by sonication twice (10 sec on/5 sec off) at medium intensity.
The extracts were rested on ice for ~5 minutes and treated with Benzonase (0.0625 U/μL, EMD Millipore) for 1 h on ice. The samples were then centrifuged at 19,000 x g at 4°C for 5 minutes and the supernatant saved as the chromatin fraction. Protein concentrations were determined with the BCA assay, and samples analyzed by Western blot. 
Western blot analysis
15-30 μg of protein, unless otherwise indicated, was run on SDS-PAGE gels and transferred to a nitrocellulose membrane. All membranes were checked with Ponceau S staining for transfer efficiency and then blocked in 5% non-fat milk in PBS plus 0.1% Tween-20 (PBST) for at least 2 h. Primary antibodies were diluted in 5% non-fat milk-PBST or PBS and incubated overnight at 4°C. Primary antibodies were removed and the membranes washed 3x for 10 minutes each in PBST. Secondary antibodies were diluted in 5% non-fat milk-PBST and incubated at least 2 h at RT. After incubation, the membranes were washed 3x for 10 minutes each in PBST. The blots were then developed with Western Lightning Plus ECL (Perkin Elmer) or ECL Prime (GE Healthcare).
Immunofluorescence
Cells were plated onto coverslips and allowed to grow to 50-70% confluency. They were incubated with 50 μM EdU for 30 minutes, where indicated. For MCM subunits, soluble proteins were pre-extracted with ice-cold 1x CSK buffer (10 mM HEPES pH 7.4, 0.3 M sucrose, 100 mM NaCl, 3 mM MgCl2, Protease Inhibitors, Phosphatase Inhibitors) containing 0.1% Triton X-100 for 2-3 min at RT. Cells were then fixed with ice-cold 100% methanol at -20°C for 10 min. Cells were then blocked in a 2% BSA/1% Fish Gelatin-PBS solution for at least 1 h at RT or overnight at 4°C.
Primary antibodies were diluted in 2% BSA/1% Fish Gelatin-PBS at 1:500 and incubated with the coverslips for at least 1 h followed by three PBST washes. Secondary antibodies were incubated at 1:1000 with the coverslips for at least 1 h at RT followed by three PBST washes. For AND-1, cells were pre-extracted and fixed as previously described . Coverslips were then blocked with 3% BSA in 1x PBS followed by incubation with 1:100 α-WDHD1 (AND1) for 1 h at RT. Following three PBST washes, the coverslips were incubated with 1:1000 goat α-rabbit AlexaFluor 594 for 30 min at RT and then washed three times with PBST. Where indicated, EdU was detected per the manufacturer's instructions (Life Technologies). All coverslips were then dehydrated using an ethanol series and mounted with FluoroGel (Electron Microscopy Sciences) containing 0.2 ug/mL DAPI. Images were taken under 60x oil immersion on an EVOS FL microscope (Thermo Fisher). The nuclear signal intensity was analyzed in ImageJ as previously described .
Cell Synchronization
Cells were plated into 10 cm dishes at ~5 x 10 5 cells/mL and allowed to grow overnight. 2 mM thymidine was added and plates were incubated for 14 h at 37°C. After 14 h, media was removed and all cells were washed three times with warm 1x PBS. Fresh media was added and cells were released for 9 h. After 9 h, a second thymidine block was initiated by the addition of 2 mM thymidine. Plates were incubated at 37°C for 16 hr. After 16 h, cells were washed three times with warm 1x PBS, and the media replaced. Samples were then collected at specific timepoints (0, 1.5, 3, 6, 9, 12, 24 h release). After collection, cells were divided for flow cytometry (see below) or fractionation and western analysis (see above).
Flow Cytometry
After cells were collected, the supernatant was removed, the samples were pre-extracted to remove soluble proteins by the addition of 500 μL of fresh 1x CSK buffer plus 0.1% Triton X-100 and incubated at RT for 5 minutes. Leaving the CSK buffer on the cells, 5 mL of ice-cold 100% methanol was then added to the tubes dropwise with gentle vortexing. Tubes were capped, inverted once, and then placed at -20°C for 10 min. Samples were inverted once during incubation to prevent clumping. 5 mL of filter-sterilized 1% BSA-PBS was then directly added to the CSK buffer/100% methanol mixture, tubes inverted several times and samples were centrifuged at 1000 x g for 5 minutes. The supernatant was removed and 5 mL of fresh, filter-sterilized 1% BSA-PBS was added to the resuspended cell pellet. Samples were stored at 4°C.
Cells were then spun down at 1000 x g for 5 minutes. The supernatant was removed and 200 μL of MCM6 antibody diluted (1:500) in 1% BSA-PBST was added to the resuspended cell pellet for at least 1 h at RT, with mild vortexing halfway through the incubation. 5 mL of 1% BSA-PBST was then added and samples spun down at 1000 x g for 5 minutes and the supernatant removed. A second wash of 5 mL 1% BSA-PBST wash was then performed. Cells were then resuspended and incubated in 250 μL of goat α-mouse AlexaFluor 647 (1:500) in 1% BSA-PBST for at least 1 h at RT, protected from light, with mild vortexing halfway through the incubation.
Cells were washed twice as described above with 5 mL of 1% BSA-PBST.
EdU was detected by Click-iT chemistry. Reaction cocktail was made according to the manufacturer's instructions (Thermo Fisher). 250 μL of the complete Click-iT reaction cocktail was added and the samples incubated at RT for 30 minutes. 5 mL of 1% BSA-PBST was then added to each tube and the samples spun down at 1000 x g for 5 minutes, the supernatant was removed and the cells resuspended in the residual liquid. 1 mL of fresh DAPI Staining Solution (200 μL 10% Triton X-100, 20 μL 1 mg/mL DAPI, 200 μL 10 mg/mL RNase, into 20 mL 1% BSA-PBS) was added and the cells were incubated for at least 15 minutes at RT. Samples were spun at 50
x g for 30 seconds to remove cell clumps and debris through filter-capped tubes (Corning) and run on a BD LSR II Flow Cytometer in the Microscopy and Flow Cytometry Facility at the University of South Carolina, College of Pharmacy. Measurements and analysis were then performed for chromatin-bound MCM6, EdU and DAPI using FlowJo (FlowJo, LLC). Gates for EdU positive cells were created using control samples lacking EdU (Figure 2B and EV2E) and gates for MCM6 positive cells were selected, using control cells without MCM6 antibody ( Figure   2D and EV2A). To separate out G1, S and G2/M populations in Figure 2E and EV2G, the following gating was performed (see Figure EV2A -D). G1 cells were EdU-cells at ~200 DAPI peak (2n). Sphase cells were EdU+ cells in the ~200-400 DAPI range (2n-4n). G2/M were EdU-cells in the ~400 DAPI range (4n), which would omit any cells entering G2 during the 30 min EdU labeling period.
Co-Immunoprecipitation (co-IP) Assay
For co-IP experiments, cells were grown overnight, such that cells were at 50-70% confluency on the day of transfection. 10 μg of total DNA was mixed with 20 μl Polyethylenimine (10 mg/ml) (Polysciences) for each transfection. Plasmids used for transfection include: pcDNA3.1-Flag-STN1 , pcDNA3.1-HA-CTC1 (Surovtseva et al., 2009 ), pTRE2-TEN1 (Wang et al., 2014) , pInducer20-Blast-CDT1-HA (a gift from Jean Cook, Addgene plasmid #109335) and pcDNA3.1 Flag-tagged MCM subunits (ORF cDNA clones from Genscript). After 48 h, cells were collected and resuspended in 500 μl lysis buffer (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM MgCl2, 0.1% Igepal) with Protease and Phosphatase inhibitors, incubated on ice for 15 min and then treated with Benzonase for 1 h at 4ºC with rotation to digest the DNA. After incubation, samples were spun down at 19,000 x g for 7 min at 4ºC and the supernatant moved to a new tube. Lysates were pre-cleared by adding 50 μL of Protein A/G bead slurry (Santa Cruz) and incubating at 4ºC for 30-60 min with rotation. Beads were pelleted at 1000 x g for 1 min at 4ºC and the supernatant collected. For IP, 30 μL of 50% M2 α-Flag (Sigma) or α-HA (Sigma) agarose bead slurry was added to 500 ug pre-cleared whole cell lysate in a total volume of 300 μL and incubated overnight at 4ºC with rotation. Beads were then pelleted by centrifugation at 1000 x g for 1 min at 4ºC and were washed four times with 1 mL of lysis buffer at 4ºC for 5 min with rotation for each wash.
Proteins were released from the beads by adding 75 μL 2x sample buffer (100mM Tris-HCl pH 6.8, 4% SDS, 20% glycerol and 0.02% bromophenol blue). Samples were boiled for 5 mins before SDS-PAGE and Western blot analysis. For quantification of the co-IP results in Figure 4B IP/MCM2(-CST) IP)=Relative CDT1 in MCM2 IP]. We also quantified CDT1 association to MCM without normalizing for CDT1 input levels and also observed a significant decrease (>50%) in CDT1 association with MCM subunits with CST expression.
Yeast Two-Hybrid Screens
The human CTC1, STN1, TEN1, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7 or CDC45 were amplified by PCR using Phusion polymerase (Thermo) from pcDNA3.1 plasmids encoding the cDNA of each protein (MCM plasmids from Genscript). The PCR products were then cloned into the pGBKT7-BD or pGADT7-AD plasmids. NdeI/SalI sites were used to link CTC1, STN1 and TEN1 to pGBKT7-BD while NdeI/XhoI sites were used for pGADT7-AD. For MCM2-7 and CDC45, EcoRI/NdeI sites were used for both plasmids. Mating was performed using Saccharomyces cerevisiae strains Y187 and AH109 transformed with pGBKT7 plasmids or pGADT7 plasmids, respectively. The pGADT7-blank or pGBKT7-blank plasmids were used as negative controls. 
Yeast Protein Extraction
Yeast cells from the selective media plates were cultured in liquid DDO medium overnight at 30ºC.
3 mL yeast culture was spun down and the supernatant discarded. The pellet was resuspended with 150 μL of 2 M LiAc, mixed thoroughly and incubated on ice for 5 min. The samples were then spun down at 850 x g for 5 min at 4ºC and the supernatant discarded. The pellet was then resuspended in 100 μL 2x sample buffer and boiled for 5 min. The samples were spun again and the supernatant transferred to a new tube. The supernatant, containing yeast whole protein, was loaded onto an SDS-PAGE gel and analyzed by Western blot.
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